Boostrix tdap vaccine syringe 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F56XQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $34,668
Award facts
- Contract value 100% obligated
- $34,668.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $34,668 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Boostrix TDAP vaccine syringes (0.5mL) with an ultimate completion date of December 22, 2025. This non-set-aside contract represents a competitive award to the major pharmaceutical distributor, which maintains its corporate office in Conshohocken, Pennsylvania—the designated place of performance. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $1 billion vehicle running through December 2026 that provides comprehensive global pharmaceutical support for military healthcare programs.
As a critical vendor in the federal medical supply chain, AmerisourceBergen fulfills essential vaccine and pharmaceutical procurement requirements for the Department of Defense and related federal health systems. The company's extensive contract portfolio with the Defense Logistics Agency demonstrates its capability to supply a wide range of pharmaceutical products and medical commodities under competitive conditions. This TDAP vaccine delivery order supports military medical readiness and healthcare operations, leveraging the established IDC framework that enables efficient procurement of critical immunization supplies across the global defense healthcare network.
Quick answers
Who was awarded contract SPE2DR26F56XQ?
SPE2DR26F56XQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 19, 2025.
How much is contract SPE2DR26F56XQ worth?
The government has obligated $34,668 on SPE2DR26F56XQ.
Is contract SPE2DR26F56XQ an order under another contract?
Yes. SPE2DR26F56XQ is a delivery order under SPE2DR25D2006, an indefinite delivery contract.
Was contract SPE2DR26F56XQ competed?
The extent of competition for SPE2DR26F56XQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award